Astria Therapeutics Inc

NASDAQ:ATXS   3:59:58 PM EDT
7.28
-0.23 (-3.06%)
Products

Astria Therapeutics Announces FDA Clearance Of IND Application For Star-0215

Published: 07/28/2022 12:21 GMT
Astria Therapeutics Inc (ATXS) - Astria Therapeutics Announces FDA Clearance of Ind Application for Star-0215, a Monoclonal Antibody Inhibitor of Plasma Kallikrein for Treatment of Hereditary Angioedema.
Astria Therapeutics Announces FDA Clearance of Ind Application for Star-0215, a Monoclonal Antibody Inhibitor of Plasma Kallikrein for Treatment of Hereditary Angioedema.